3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
26
Prostatic Neoplasms
5
Osteosarcoma
5
Neuroendocrine Tumors
5
Neoplasms
5
Kidney Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Neoplasm Metastasis
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Sarcoma, Ewing
3
Sarcoma
3
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Medullary
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Small Cell Lung Carcinoma
2
Penile Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma
2
Adrenocortical Carcinoma
2
von Hippel-Lindau Disease
1
Wilms Tumor
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Interventions
Specimen Handling
12
Magnetic Resonance Spectroscopy
12
Temozolomide
11
Radiotherapy
8
Radiation
5
Surgical Procedures, Operative
3
Biopsy
3
trametinib
2
dabrafenib
2
Spinal Puncture
2
Radiotherapy, Intensity-Modulated
2
Genetic Therapy
2
Craniotomy
2
Bevacizumab
2
vorasidenib
1
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
tocilizumab
1
ribociclib
1
pembrolizumab
1
atezolizumab
1
abexinostat
1
Vorinostat
1
Transurethral Resection of Bladder
1
Standard of Care
1
Restraint, Physical
1
Protons
1
Proton Therapy
1
Practice Guidelines as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
cabozantinib
×
90 days
×
Clear all
No trials found.